Загрузка...
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
BACKGROUND: There are no effective treatments or validated clinical response markers in systemic sclerosis (SSc). We assessed imaging biomarkers and performed gene expression profiling in a single-arm open-label clinical trial of tyrosine kinase inhibitor dasatinib in patients with SSc-associated in...
Сохранить в:
Опубликовано в: : | PLoS One |
---|---|
Главные авторы: | , , , , , , , , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Public Library of Science
2017
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5679625/ https://ncbi.nlm.nih.gov/pubmed/29121645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0187580 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|